Rosoux, A., Duplaquet, F., & Ocak, S. (2017). Good Tolerance to Full-Dose Crizotinib in a Patient with Anaplastic Lymphoma Receptor Tyrosine Kinase-Rearranged Lung Adenocarcinoma and Preexisting Renal Impairment. Case Rep Oncol.
Style de citation ChicagoRosoux, Adeline, Fabrice Duplaquet, et Sebahat Ocak. "Good Tolerance to Full-Dose Crizotinib in a Patient With Anaplastic Lymphoma Receptor Tyrosine Kinase-Rearranged Lung Adenocarcinoma and Preexisting Renal Impairment." Case Rep Oncol 2017.
Style de citation MLARosoux, Adeline, Fabrice Duplaquet, et Sebahat Ocak. "Good Tolerance to Full-Dose Crizotinib in a Patient With Anaplastic Lymphoma Receptor Tyrosine Kinase-Rearranged Lung Adenocarcinoma and Preexisting Renal Impairment." Case Rep Oncol 2017.